CME Credits

 

The 10th ImmunoTherapy of Cancer Conference, March 21 - 23, 2024 will apply for accredition from the European Accreditation Council for Continuing Medical Education (EACCME®). 

The outcome will be posted here as soon as available.

​Ethical MedTech Compliance

​

ITOC10 has been submitted for pre-clearance of the conference - the reviewing process by Ethical Med Tech is currently ongoing (EMT33870).

​

The 10th ImmunoTherapy of Cancer Conference will adhere to the Code of Practice and supports the Eucomed Guidelines on Interactions with Healthcare Professionals (EthicalMedTech).

​

Ethical Med Tech Conference Vetting System

The Conference Vetting System is a centralised decision-making system that encourages transparency and consistency in medical conferences and alleviates the complex administrative burden previously faced by Eucomed members, who were constrained to make their own determinations on whether or not a conference is compliant with the Code.

For further details please visit the Ethical MedTech Website

​

​